CLOVIS ONCOLOGY INC (CLVS) Forecast, Price Target & Analyst Ratings

NASDAQ:CLVS • US1894641000

Current stock price

0.0812 USD
0 (-5.58%)
At close:
0.078 USD
0 (-3.94%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLOVIS ONCOLOGY INC (CLVS).

Forecast Snapshot

Consensus Price Target

Price Target
$2.04
+ 2,412.32% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 21, 2023
Period
Q4 / 2022
EPS Estimate
-$0.32
Revenue Estimate
32.17M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
42.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$2.04
Upside
+ 2,412.32%
From current price of $0.08 to mean target of $2.04, Based on 7 analyst forecasts
Low
$2.02
Median
$2.04
High
$2.10

Price Target Revisions

1 Month
0.00%
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for CLVS. The average price target is 2.04 USD. This implies a price increase of 2412.32% is expected in the next year compared to the current price of 0.0812.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLVS Current Analyst RatingCLVS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

CLVS Historical Analyst RatingsCLVS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
42.86%
CLVS was analyzed by 7 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CLVS.
In the previous month the buy percentage consensus was at a similar level.
CLVS was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-11-10JP MorganDowngrade Neutral -> Underweight
2022-05-06HC Wainwright & Co.Downgrade Buy -> Neutral
2022-05-05HC Wainwright & Co.Maintains Buy
2021-09-21HC Wainwright & Co.Maintains Buy
2021-08-05HC Wainwright & Co.Maintains Buy
2021-05-05HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 21, 2023
Period
Q4 / 2022
EPS Estimate
-$0.32
Revenue Estimate
32.17M
Revenue Q2Q
-10.56%
EPS Q2Q
34.13%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

CLVS is expected to report earnings on 2/21/2023. The consensus EPS estimate for the next earnings is -0.32 USD and the consensus revenue estimate is 32.17M USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2022 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
CLVS revenue by date.CLVS revenue by date.
143M
49.90%		164.5M
15.03%		148.757M
-9.57%		131.8M
-11.40%		158.8M
20.49%		172.03M
8.33%		183.24M
6.52%		187.99M
2.59%
EBITDA
YoY % growth
CLVS ebitda by date.CLVS ebitda by date.
-359.53M
-9.21%		-293.9M
18.25%		-211.795M
27.94%		-186.66M
11.87%		-106.08M
43.17%		-34.68M
67.31%		-73.736M
-112.62%		-110.958M
-50.48%
EBIT
YoY % growth
CLVS ebit by date.CLVS ebit by date.
-367.3M
-10.04%		-302.1M
17.75%		-220.291M
27.08%		-199.327M
9.52%		-142.434M
28.54%		-97.439M
31.59%		-133.425M
-36.93%		-174.813M
-31.02%
Operating Margin
CLVS operating margin by date.CLVS operating margin by date.
-256.85%-183.65%-148.09%-151.23%-89.69%-56.64%-72.81%-92.99%
EPS
YoY % growth
CLVS eps by date.CLVS eps by date.
-7.49
-5.94%		-4.34
42.06%		-2.29
47.24%		-1.64
28.29%		-0.80
51.24%		-0.48
40.13%		-0.68
-42.83%		-1.00
-45.68%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 22
EPS
Q2Q % growth		-0.32
34.13%
Revenue
Q2Q % growth		32.17M
-10.56%
EBITDA
Q2Q % growth		-38.76M
12.34%
EBIT
Q2Q % growth		-41.557M
21.16%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLVS Yearly Revenue VS EstimatesCLVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
CLVS Yearly EPS VS EstimatesCLVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.43%
EPS Next 5 Year
9.36%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.93%
Revenue Next 5 Year
4.17%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
22.73%
EBIT Next 5 Year
8.67%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CLOVIS ONCOLOGY INC / CLVS Forecast FAQ

What do analysts expect the price target to be for CLOVIS ONCOLOGY INC (CLVS)?

7 analysts have analysed CLVS and the average price target is 2.04 USD. This implies a price increase of 2412.32% is expected in the next year compared to the current price of 0.0812.

When does CLOVIS ONCOLOGY INC (CLVS) report earnings?

CLOVIS ONCOLOGY INC (CLVS) will report earnings on 2023-02-21.

What are the consensus estimates for CLOVIS ONCOLOGY INC (CLVS) next earnings?

The consensus EPS estimate for the next earnings of CLOVIS ONCOLOGY INC (CLVS) is -0.32 USD and the consensus revenue estimate is 32.17M USD.

How many analysts cover CLOVIS ONCOLOGY INC (CLVS) stock?

The number of analysts covering CLOVIS ONCOLOGY INC (CLVS) is 7.